Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Definium Therapeutics Inc. Common Shares (DFTX) vs GoPro Inc (GPRO) Price & Performance

Definium Therapeutics Inc. Common SharesTrade

Price performance (Past 24H)

Key statistics

Definium Therapeutics Inc. Common Shares vs GoPro Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while GoPro Inc trades at $1.19 (market cap $253.82M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 18.6× GoPro Inc's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and GoPro Inc for 45 Days on average.

DFTXGPRO
Market Cap
$4.71B$253.82M
Volume
1,966,6369,909,466
Sector
HealthTechnology
52-Week High
$48.45$2.35
52-Week Low
$10.68$0.58
Typical Hold Time
0 Days45 Days
Enterprise Value
$3.67B$312.60M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Definium Therapeutics Inc. Common Shares

No Aura AI signal available yet.

GoPro Inc

GoPro (GPRO) trades at $1.18, down 10.61% today amid volatile trading following recent merger announcements. The stock shows bullish technical signals with oversold RSI conditions, while fundamentally the company faces significant challenges with negative profit margins and declining revenue. Recent developments include a proposed $285 million merger with Starman Optical and influencer Markiplier taking an 8.5% stake, driving substantial price volatility.

Investment outlook remains highly speculative with the merger offering potential upside from the $1.14 buyout price, but fundamental weakness and negative cash flow pose substantial risks. Analyst sentiment is mixed with only 21% recommending buy, while ongoing investigations into the merger's fairness add uncertainty to the transaction's completion.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DFTX
100% Buy0% Sell
Avg holding period · 0 Days
GPRO
92% Buy8% Sell
Avg holding period · 45 Days

About Definium Therapeutics Inc. Common Shares

Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.

Read more on DFTX →

About GoPro Inc

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.

Read more on GPRO →